124 related articles for article (PubMed ID: 3575721)
1. Sr-89 therapy for metastatic bone disease: scintigraphic and radiographic follow-up.
Kloiber R; Molnar CP; Barnes M
Radiology; 1987 Jun; 163(3):719-23. PubMed ID: 3575721
[TBL] [Abstract][Full Text] [Related]
2. [Radiologic follow-up and prognosis of efficiency of systemic Sr-89 Cl-2 therapy of bone metastases in prostate cancer].
Barysheva EV; Obradovic V; Stefanovic L; Riannel' IuE; Regoe S; Selivanov SP; Artiko V; Isaeva SN; Velichko SA; Tuzikov SA; Ussov VIu
Vestn Rentgenol Radiol; 2000; (6):46-50. PubMed ID: 12717912
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of symptomatic bone metastases of prostatic carcinoma using strontium chloride (Sr-89)].
Dormia E; Mantovani F; Minervini S; Malagola G; Castellani R; Dormia G; Gonnella G; Mazza L; Luongo P; Bertana F
Arch Ital Urol Androl; 1993 Apr; 65(2):161-6. PubMed ID: 8330061
[TBL] [Abstract][Full Text] [Related]
4. Use of bone scintigraphy to select patients with multiple myeloma for treatment with strontium-89.
Edwards GK; Santoro J; Taylor A
J Nucl Med; 1994 Dec; 35(12):1992-3. PubMed ID: 7989983
[TBL] [Abstract][Full Text] [Related]
5. Strontium and samarium therapy for bone metastases from prostate carcinoma.
Dickie GJ; Macfarlane D
Australas Radiol; 1999 Nov; 43(4):476-9. PubMed ID: 10901963
[TBL] [Abstract][Full Text] [Related]
6. Results of 89strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report.
Firusian N; Mellin P; Schmidt CG
J Urol; 1976 Dec; 116(6):764-8. PubMed ID: 1003647
[TBL] [Abstract][Full Text] [Related]
7. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
[TBL] [Abstract][Full Text] [Related]
8. [Strontium-89 for bone metastases from prostate cancer: an update].
Zhao WW; Xie P; Deng HF
Zhonghua Nan Ke Xue; 2010 Mar; 16(3):269-72. PubMed ID: 20369560
[TBL] [Abstract][Full Text] [Related]
9. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
10. Palliation of multiple bone metastases from prostatic carcinoma with strontium-89.
Tennvall J; Darte L; Lundgren R; el Hassan AM
Acta Oncol; 1988; 27(4):365-9. PubMed ID: 2462438
[TBL] [Abstract][Full Text] [Related]
11. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
[TBL] [Abstract][Full Text] [Related]
12. Strontium-89 therapy and imaging with bremsstrahlung in bone metastases.
Uchiyama M; Narita H; Makino M; Sekine H; Mori Y; Fukumitsu N; Kawakami K
Clin Nucl Med; 1997 Sep; 22(9):605-9. PubMed ID: 9298293
[TBL] [Abstract][Full Text] [Related]
13. Strontium 89 for palliation of bone metastases.
Reddy EK; Robinson RG; Mansfield CM
J Natl Med Assoc; 1986 Jan; 78(1):27-32. PubMed ID: 2419578
[TBL] [Abstract][Full Text] [Related]
14. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.
Breen SL; Powe JE; Porter AT
J Nucl Med; 1992 Jul; 33(7):1316-23. PubMed ID: 1613572
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
Ouyang W; Liu JH; Liu WY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
[TBL] [Abstract][Full Text] [Related]
16. Systemic radionuclide therapy of bone metastases with strontium-89.
Porter AT; Davis LP
Oncology (Williston Park); 1994 Feb; 8(2):93-6; discussion 96, 99-101. PubMed ID: 8167090
[TBL] [Abstract][Full Text] [Related]
17. 89Strontium therapy of bone metastases of carcinoma of the prostatic gland.
Correns HJ; Mebel M; Buchali K; Schnorr D; Seidel C; Mitterlechner E
Eur J Nucl Med; 1979 Feb; 4(1):33-5. PubMed ID: 499225
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide-targeted therapy for the management of metastatic bone pain.
Ackery D; Yardley J
Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
[TBL] [Abstract][Full Text] [Related]
19. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma.
Kalin B; Jacobsson H
Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278
[No Abstract] [Full Text] [Related]
20. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
Kurosaka S; Satoh T; Chow E; Asano Y; Tabata K; Kimura M; Tsumura H; Matsumoto K; Ishiyama H; Inoue Y; Hayakawa K; Baba S
Ann Nucl Med; 2012 Jul; 26(6):485-91. PubMed ID: 22477263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
